James Mulay

Director

James Mulay (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in CG Oncology, Inc. (CGON). The largest single filing was $1.8M of CGON (24,165 sh × $75.16, as filed), executed Jul 10.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.8M

shares × price, as filed

Last traded

Jul 10

Filed Jul 14

Median ADV $76.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $6.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

CGON CG Oncology, Inc. CGON · 0 buys · 7 sells 7 filings

Recent filings

CGONSALE CG Oncology, Inc. View filing → $1.8M
24,165 sh × $75.16
Exec Jul 10
Filed Jul 14 · 4:15 PM ET CGONSALE CG Oncology, Inc. View filing → $1.1M
15,600 sh × $73.01
Exec Apr 17
Filed Apr 20 · 5:30 PM ET CGONSALE CG Oncology, Inc. View filing → $556K
10,491 sh × $52.99
Exec Jan 9
Filed Jan 13 · 5:30 PM ET CGONSALE CG Oncology, Inc. View filing → $260K
5,903 sh × $43.99
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET CGONSALE CG Oncology, Inc. View filing → $500K
12,755 sh × $39.19
Exec Sep 29 2025
Filed Sep 30 2025 · 5:30 PM ET CGONSALE CG Oncology, Inc. View filing → $885K
22,686 sh across 2 lots
Exec Sep 18 2025
Filed Sep 22 2025 · 5:30 PM ET CGONSALE CG Oncology, Inc. View filing → $852K
27,015 sh across 4 lots
Exec Sep 5 2025
Filed Sep 8 2025 · 5:30 PM ET